You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
港股異動 | 三葉草生物-B盤中漲9% 獲CEPI追加投資達3690萬美元
格隆匯 11-19 14:08
格隆匯11月19日丨三葉草生物(2197.HK)下午大幅拉昇,盤中漲9.71%,報12.88港元,總市值149億港元。三葉草生物-B發佈公吿,CEPI已於2021年11月18日批准公司於2021年11月11日所提出對CEPI資助協議作出變更的請求,據此,考慮到評估三葉草生物的三聚體重組蛋白及已添加佐劑的COVID-19疫苗的保護效力及安全性研究(SPECTRA)II/III期關鍵性研究的積極結果,CEPI及公司互相同意在資助承諾的基礎上增加最多3690萬美元的額外預算,以為SCB-2019(CpG1018加鋁佐劑)臨牀開發所需的以下SPECTRAII/III期臨牀活動提供資金:(i)擴大的研究樣本規模;(ii)因輔助策略變動而拉長的時間線;(iii)納入交叉對照組的安全性隨訪;(iv)納入加強劑組以評估同源加強劑反應;(v)青少年受試者人數增加及納入對青少年與青壯年之間的非劣效性測試對比。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.
uSMART
Wealth Growth Made Easy
Open Account